300110.SZ
Huaren Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 2.80
−2.10%Margins
Gross margin
36.3%
EBITDA margin
-25.6%
EBIT margin
-33.9%
Net margin
-34.9%
FCF margin
21.1%
-54.2%
Return on equity
-16.6%
Return on assets
-25.6%
Return on invested capital
0.48x
Asset turnover
CNY 307.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026